Triple negative breast cancer accounts for around 15% of breast cancers, and it is a more diagnosis common in younger women. This subtype of breast cancer tends to share similarities with BRCA-related disease, being more likely to be linked to faulty DNA repair and reprogrammed cellular metabolism. TNBC tumours don’t exhibit the over-expression of oestrogen and growth receptors found in other forms of breast cancer, and this lack of modifiable receptors tends to be seen as bad news. But all it really means is that we don’t currently have any specific adjuvant medical treatments, which makes it all the more important to look for other modifiable factors, such as diet and lifestyle.Continue reading
When I cured myself of irreversible, pre-cancerous proliferative verrucous leukoplakia (PVL) my specialist surgeon was, I think it’s fair to say, gobsmacked. It’s something he had never seen before, and believed to be impossible. The five nasty white patches on my tongue melted away leaving a perfect pink patina, in five months flat.
One of the nicest things that happened for me in 2018 was being featured in IHCAN Magazine, the official publication for complementary medicine practitioners. As it’s not available to the general public I’m re-blogging the article here so you can see what I’ve been up to, and maybe even learn a bit more about me…
On 13 October I will be joining Dr Etienne Callebout and Dr Marcus Stanton at the Cavendish Conference Centre for a day that will focus on breast cancer and immunity. I will be talking about personalised breast cancer protocols and the methods I use to help clients identify and manage personal risk factors in order to optimise health and happiness after diagnosis. The event is aimed at a professional audience and you can book your ticket at http://www.nouveauhealth.co.uk. Come and say hello!